Background
==========

Strategies that enhance the function of T cells are critical for immunotherapy.

Methods
=======

Here we described for the first time a non-viral mediated approach to reprogram primary human T cells by disruption of PD-1.

Results
=======

We showed that the gene knockout of PD-1 by electroporation of plasmids encoding sgRNA and Cas9 was technically feasible. The disruption of PD-1 resulted in significant reduction of PD-1 expression but didn\'t affect the viability of primary human T cells. Cellular immune response of the gene modified T cells was characterized by up-regulated IFN-γ production and enhanced cytotoxicity.

Conclusions
===========

These results suggest that we have established an approach for efficient checkpoint inhibitor disruption, providing a new strategy for targeting checkpoint inhibitors to improve the efficacy of T cell based adoptive therapies.
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